mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.07 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.07 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |